• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Moderna, Inc. - Common Stock (NQ:MRNA)

    189.04 -14.17 (-6.97%)
    Delayed Quote Updated: 10:24 AM EDT, Oct 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Moderna, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    Stay informed with the top movers within the S&P500 index on Wednesday. ↗
    Via Chartmill
    News headline image
    Moderna Stock Moves Lower Wednesday: What's Going On? ↗
    Shares of Moderna Inc (NASDAQ: MRNA) are trading lower Wednesday morning, taking a breather following a 170% surge over the trailing month. 
    Via Benzinga
    Wednesday's session: gap up and gap down stock in the S&P500 index ↗
    Via Chartmill
    Wednesday's pre-market session: top gainers and losers in the S&P500 index ↗
    Via Chartmill
    Exploring the top movers within the S&P500 index during today's session. ↗
    Via Chartmill
    Which S&P500 stocks are moving on Tuesday? ↗
    Via Chartmill
    News headline image
    Moderna Stock Climbs Tuesday: What's Going On? ↗
    Moderna Inc (NASDAQ: MRNA) shares are trading higher Tuesday morning. Here's what investors need to know. 
    Via Benzinga
    News headline image
    Moderna to Present at Upcoming Conferences in September 2026
    From Moderna, Inc.
    Via ACCESS Newswire
    News headline image
    Moderna Stock More Than Doubled in August. Is the Stock a Buy, a Hold, or a Sell? ↗
    The company may be on track to its next product. 
    Via The Motley Fool
    Uncover the latest developments among S&P500 stocks in today's session. ↗
    Via Chartmill
    What's going on in today's pre-market session: S&P500 movers ↗
    Via Chartmill
    News headline image
    Is It Too Late to Buy Moderna Stock After Its 127% Surge? ↗
    Moderna could be on the verge of a breakthrough, but the biotech's MRNA cancer vaccine catalyst is overly priced in. 
    Via The Motley Fool
    News headline image
    VOO vs. RSP: If AI Stocks Get Too Concentrated, Here's Which One I'd Choose ↗
    These ETFs both hold S&P 500 members but with very different allocations. 
    Via The Motley Fool
    Topics Artificial Intelligence ETFs Stocks
    What's going on in today's session: S&P500 gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes
    From Moderna, Inc.
    Via ACCESS Newswire
    News headline image
    Q2 Earnings Highlights: Moderna (NASDAQ:MRNA) Vs The Rest Of The Therapeutics Stocks
    Wrapping up Q2 earnings, we look at the numbers and key takeaways for the therapeutics stocks, including Moderna (NASDAQ:MRNA) and its peers. Over the next f... 
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
    From Moderna, Inc.
    Via ACCESS Newswire
    What's going on in today's session: S&P500 movers ↗
    Via Chartmill
    Thursday's session: top gainers and losers in the S&P500 index ↗
    Via Chartmill
    Which S&P500 stocks are gapping on Thursday? ↗
    Via Chartmill
    These S&P500 stocks that are showing activity before the opening bell on Thursday. ↗
    Via Chartmill
    News headline image
    Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes
    From Moderna, Inc.
    Via ACCESS Newswire
    What's going on in today's session: S&P500 movers ↗
    Via Chartmill
    These S&P500 stocks are gapping in today's session ↗
    Via Chartmill
    News headline image
    A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
    EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:BNTX),(NYSE:AZN),(NASDAQ:MRNA),(NYSE:BMY) EQNX::TICKER_END 
    Via FinancialNewsMedia
    News headline image
    A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
    A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology 
    From MarketNewsUpdates.com
    Via GlobeNewswire
    Top S&P500 movers in Wednesday's pre-market session ↗
    Via Chartmill
    Top S&P500 movers in Tuesday's session ↗
    Via Chartmill
    Which S&P500 stocks are the most active on Tuesday? ↗
    Via Chartmill
    In today's session, these stocks are experiencing unusual volume. ↗
    Via Chartmill
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.